跳至主要内容
临床试验/TCTR20180321001
TCTR20180321001招募中4 期

A randomized, double-blinded, controlled trial of adding a short burst of corticosteroid to the conventional treatment of H1 antihistamines

Rachada0 个研究点目标入组 69 人开始时间: 2018年3月21日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • Patients visit emergency room at King chulalongkorn memorial hospital (KCMH) age between 18-50 years who meet the following criteria of acute urticarial such as
  • 1.eruption of wheals, central swelling of various sizes, with or without surrounding erythema; with or without angioedema
  • 2.pruritus or occasional burning sensation
  • 3.skin returning to normal appearance, usually within 1-24 hours

排除标准

  • 1.patients who have urticarial for more than 48 hours
  • 2.have severe underlying disease such as heart disease, kidney disease, liver disease
  • 3.pregnancy
  • 4.history of CPM, steroid, antihistamines allergy
  • 5.history of antihistamine or steroid uses within 48 hours before ED visit
  • 6. diabetes mellitus
  • 7.suspected of more severe disease or severe allergic reaction
  • 8.patients who don’t have puritus
  • 9.patients who have history of chronic urticaria

研究者

发起方
Rachada

相似试验